Rma Group Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Rma Group Sp. z o.o. (Poland)

Main Activities: Medical Equipment and Supplies Manufacturing

Secondary Activities: Other Basic Organic Chemical Manufacturing | Machinery, Equipment, and Supplies Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Automobile Dealers | Pharmacies and Drug Stores | All Other General Merchandise Stores | Taxi Service | Other Transit and Ground Passenger Transportation | Research and Development in the Physical, Engineering, and Life Sciences

Full name: Rma Group Sp. z o.o.

Profile Updated: October 05, 2025

Rma Group Sp. z o.o. is an enterprise based in Poland. Its main office is in Bor. The company operates in the Medical Equipment and Supplies Manufacturing industry. It was first established on January 16, 2023. Its’ total assets recorded a negative growth of 40.03%.

Headquarters
Bor 4
Bor; Lubelskie; Postal Code: 24-340

Contact Details: Purchase the Rma Group Sp. z o.o. report to view the information.

Website: http://tips-sorter.pl

Basic Information

Registered Capital:

Purchase the Rma Group Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Rma Group Sp. z o.o. report to view the information.

Incorporation Date:

January 16, 2023

Key Executives

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

75%

Purchase this report to view the information.

25%

Company Performance

Financial values in the chart are available after Rma Group Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

-5.94%▼

EBITDA

-5.94%▼

Net Profit (Loss) for the Period

-5.94%▼

Total assets

-40.03%▼

Total equity

-64.84%▼

Return on Equity (ROE)

-123.2%▼